Journal
BIOLOGICAL & PHARMACEUTICAL BULLETIN
Volume 41, Issue 3, Pages 342-349Publisher
PHARMACEUTICAL SOC JAPAN
DOI: 10.1248/bpb.b17-00667
Keywords
protamine sulfate; chondroitin sulfate sodium; gene delivery; plasmid DNA; medical product
Categories
Funding
- Japan Society for the Promotion of Science (JSPS) KAKENHI [26860107]
- Grants-in-Aid for Scientific Research [26860107] Funding Source: KAKEN
Ask authors/readers for more resources
We developed and optimized a novel gene delivery vector constructed electrostatically with an anionic biological component and a cationic biological component. Cationic binary complexes of plasmid DNA (pDNA) with novo-protamine sulfate as a medical product (PRT complexes) demonstrated high gene expression with minimal cytotoxicity, likely related with its total cationic charge. Subsequently, anionic compounds were added to the PRT complexes to form ternary complexes with neutral or anionic charges. Among the anionic compounds examined, chondroitin sulfate sodium (CS) as a medical product encapsulated the PRT complexes to produce stable ternary complexes (CS complexes) at charge ratios of >= 4 with pDNA. CS complexes exhibited high gene expression without cytotoxicity in mouse melanoma cell line, B16-F10 cells, in vitro. An inhibition study with endocytosis inhibitors suggested that PRT complexes were mainly taken up by caveolae-mediated endocytosis, and CS complexes were mainly taken up by clathrin-mediated endocytosis in B16-F10 cells. We found that CS complexes including pDNA encoding Oplophorus gracilirostris luciferase induced selective gene expression in the spleen after intravenous administration into ddY male mice. Thus, we successfully constructed useful gene vectors with biological components as medical products.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available